 SOUTH SAN FRANCISCO, Calif., Aug. 10, 2021 PRNewswire -- IDEAYA Biosciences, Inc. Nasdaq: IDYA, a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the second quarter ended June 30, 2021. 